Fatality caused by a combined trimipramine-citalopram intoxication

Forensic Science International

Volumn 106, Issue 2, 1999, Pages 125-131

  Musshoff, F ^a   Schmidt, P ^a   Madea, B ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Citalopram; Fatality; Intoxication; Suicide; Trimipramine

Indexed keywords

CITALOPRAM; DRUG METABOLITE; NORCITALOPRAM; NORTRIMIPRAMINE; TRIMIPRAMINE;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; CAUSE OF DEATH; DEPRESSION; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG LIVER LEVEL; DRUG OVERDOSE; FATALITY; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SUICIDE;

EID: 0032760610     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0379-0738(99)00183-8     Document Type: Article

References (33)

1. Lapierre Y.D. A review of trimipramine - 30 years clinical use. Drugs. 38:1989;17-24.
2. Moffat A.C., Jackson J.V., Widdop B. Clarke's Isolation and Identification of Drugs. 2nd edn :1986;Pharmaceutical Press, London.
3. Lindegaard Pedersen O., Kragh-Sørensen P., Bjerre M., Overø K.F., Gram L.F. Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect. Psychopharmacology. 77:1982;199-204.
4. Kragh-Sørensen P., Overø K.F., Lindegaard Pedersen O., Jensen K., Parnas W. The kinetics of citalopram: single and multiple dose studies in man. Acta. Pharmacol. Toxicol. 48:1981;53-60.
5. Overø K.F. Kinetics of citalopram in man; plasma levels in patients. Prog. Neuropsychopharmacol. Biol. Psychiatry. 6:1982;311-318.
6. Pfleger K., Maurer H.H., Weber A. Mass Spectral and Gc Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites. 2nd edn :1992;VCH - Verlagsgesellschaft, Weinheim.
7. Frommer D.A., Kulig K.W., Marx J.A., Rumack B. Tricyclic antidepressant overdose. A review. J. Am. Med. Asssoc. 257:1987;521-526.
8. Hebb J.H., Caplan Y.H., Crooks C.R., Mergner W.J. Blood and tissue concentrations of tricyclic antidepressant drugs in postmortem cases: literature survey and a study of forty deaths. J. Anal. Toxicol. 6:1982;209-216.
9. Baselt R.C., Cravey R.H. Disposition of Toxic Drugs and Chemicals in Man. 4th ed :1995;Biomedical Publications, Davis, CA.
10. Fraser A.D., Isner A.F., Perry R.A. Distribution of trimipramine and its major metabolites in a fatal overdose case. J. Anal. Toxicol. 11:1987;168-170.
11. Meatherall R.C., Guay D.R.P., Nokes J.M., Keenan J.R. Toxicological findings in a death resulting from the ingestion of trimipramine. J. Forensic. Sci. 28:1983;1023-1029.
12. Druid H., Holmgren P. Fatal seizures associated with trimipramine poisoning. Forensic Sci. Int. 49:1991;75-79.
13. Druid H., Holmgren P. A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J. Forensic. Sci. 42:1997;79-87.
14. Crome P. Antidepressant overdose. Drugs. 23:1982;431-461.
15. Rose J.B. Tricyclic antidepressant toxicity. Clin. Toxicol. 11:1977;391-402.
16. Prouty R.W., Anderson W.H. The forensic science implications of site and temporal influences on postmortem blood-drug concentrations. J. Forensic Sci. 35:1990;243-270.
17. Öström M., Eriksson A., Thorson J., Spigset O. Fatal overdose with citalopram. Lancet. 348:1996;339-340.
18. Zehnder M., Hohnloser S., Just H. QT-interval prolonging drugs: mechanism and clinical relevance of their arrhythmogenic hazards. Cardiovasc. Drugs Ther. 5:1991;515-530.
19. Boeck V., Fredricson Overö K., Svendsen O. Studies on acute toxicity and drug levels of citalopram in the dog. Acta Pharmacol. Toxicol. 50:1982;160-174.
20. Neuvonen P.J., Pohjola-Sintonen S., Tackle U., Vouri E. Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdose. Lancet. 342:1993;1419.
21. Grundemar L., Wohlfart B., Lagerstedt C., Bengtsson F., Eklundh G. Symptoms and signs of severe citalopram overdose. Lancet. 349:1997;1602.
22. Personne M., Persson H., Sjöberg G. Citalopram toxicity. Lancet. 350:1997;518-519.
23. Personne M., Sjöberg G., Persson H. Citalopram overdose - Review of cases treated in Swedish hospitals. Clin. Toxicol. 35:1997;237-240.
24. Fischer P. Serotonin syndrome in the elderly after antidepressive monotherapy. J Clin. Psychopharmacol. 15:1995;440-442.
25. Spigset O., Adielsson G. Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction. Int. Clin. Psychopharmacol. 12:1997;61-63.
26. Worm K., Dragsholt C., Simonsen K., Kringsholm B. Citalopram concentrations in samples from autopsies and living persons. Int. J. Legal Med. 111:1998;188-190.
27. Crewe H.K., Lennard M.S., Tucker G.T., Woods F.R., Haddock R.E. The effect of selective serotonine re-uptake inhibitors on cytochrme P4502D6 (CYP2D6) activity in human liver microsomes. Br. J. Clin. Pharm. 34:1992;262-265.
28. Baettig D., Bondolfi G., Montaldi S., Amey M., Baumann P. Tricyclic antidepressant plasma levels after augmentation with citalopram: a case study. Eur. J. Clin. Pharmacol. 44:1993;403-405.
29. Seifritz E., Holsboer-Trachsler E., Hemmeter U., Eap C.B., Baumann P. Increased trimipramine plasma levels during fluvoxamine comedication. Eur. Neuropsychopharmacology. 4:1994;15-20.
30. Bailey D.N., van Dyke C., Lagou R.A., Jatlow P.I. Tricyclic antidepressants: plasma levels and clinical findings in overdose. Am. J. Psychiatry. 135:1978;1325-1328.
31. Bailey D.N., Shaw R.F. Tricyclic antidepressants: interpretation of blood and tissue levels in fatal overdose. J. Anal. Toxicol. 3:1979;43-46.
32. Apple F.S., Bandt C.M. Liver and blood postmotem tricyclic antidepressant concentrations. Am. J. Clin. Pathol. 89:1988;794-796.
33. Apple F.S. Postmortem tricyclic antidepressant concentrations: assesing cause of death using parent drug to metabolite ratio. J. Anal. Toxicol. 13:1989;197-198.